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INVESTIGATION

Exome Sequencing Identiﬁes a Rare HSPG2 Variant
Associated with Familial Idiopathic Scoliosis
Erin E. Baschal,* Cambria I. Wethey,* Kandice Swindle,* Robin M. Baschal,† Katherine Gowan,‡
Nelson L.S. Tang,§ David M. Alvarado,** Gabe E. Haller,** Matthew B. Dobbs,**,††
Matthew R.G. Taylor,‡‡ Christina A. Gurnett,**,§§ Kenneth L. Jones,‡ and Nancy H. Miller*,†,1
*Department of Orthopedics, University of Colorado Denver Anschutz Medical Campus, Aurora, Colorado 80045,
†Musculoskeletal Research Center, Children’s Hospital Colorado, Aurora, Colorado 80045, ‡Department of Biochemistry,
University of Colorado Denver Anschutz Medical Campus, Aurora, Colorado 80045, §Department of Chemical Pathology
and Li Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR,
**Department of Orthopaedic Surgery, Washington University School of Medicine, St. Louis, Missouri 63130, ††Saint
Louis Shriners Hospital for Children, St. Louis, Missouri 63131, ‡‡Department of Cardiology, University of Colorado
Denver Anschutz Medical Campus, Aurora, Colorado 80045, and §§Department of Neurology, Washington University
School of Medicine, St. Louis, Missouri 63130

ABSTRACT Idiopathic scoliosis occurs in 3% of individuals and has an unknown etiology. The objective of this study
was to identify rare variants that contribute to the etiology of idiopathic scoliosis by using exome sequencing in
a multigenerational family with idiopathic scoliosis. Exome sequencing was completed for three members of this
multigenerational family with idiopathic scoliosis, resulting in the identiﬁcation of a variant in the HSPG2 gene as
a potential contributor to the phenotype. The HSPG2 gene was sequenced in a separate cohort of 100 unrelated
individuals affected with idiopathic scoliosis and also was examined in an independent idiopathic scoliosis population. The exome sequencing and subsequent bioinformatics ﬁltering resulted in 16 potentially damaging and rare
coding variants. One of these variants, p.Asn786Ser, is located in the HSPG2 gene. The variant p.Asn786Ser also is
overrepresented in a larger cohort of idiopathic scoliosis cases compared with a control population (P = 0.024).
Furthermore, we identiﬁed additional rare HSPG2 variants that are predicted to be damaging in two independent
cohorts of individuals with idiopathic scoliosis. The HSPG2 gene encodes for a ubiquitous multifunctional protein
within the extracellular matrix in which loss of function mutation are known to result in a musculoskeletal phenotype
in both mouse and humans. Based on these results, we conclude that rare variants in the HSPG2 gene potentially
contribute to the idiopathic scoliosis phenotype in a subset of patients with idiopathic scoliosis. Further studies must
be completed to conﬁrm the effect of the HSPG2 gene on the idiopathic scoliosis phenotype.

Idiopathic scoliosis (IS) [MIM: %181800] is a common inherited disorder
of the immature skeleton, affecting 3% of the pediatric population, with
girls characteristically more severely affected than boys (Asher and
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Burton 2006). Clinically, IS is deﬁned as a structural lateral spinal curvature of $10 with a rotatory component, documented by radiographic
analysis and occurring in otherwise-normal children. Current treatment
modalities are limited to observation, physical therapy, bracing, and
surgery. Signiﬁcant curves in adolescence can lead to severe curve
progression in adulthood. In an effort to prevent severe progression
and deformity as an adult, these adolescents may elect to undergo an
operative spinal instrumentation and fusion, a costly procedure with
life-long implications. These methods focus on the physical symptoms
and cosmetic deformity but fail to address the need for preventative
options.
The familial nature of IS is well established, but the mode of
inheritance is not clear (Cowell et al. 1972; Riseborough and WynneDavies 1973; Bonaiti et al. 1976; Czeizel et al. 1978; Tang et al. 2012).
It is unlikely that IS families are homogeneous with respect to their

Volume 5 |

February 2015

|

167

genetic architecture but represent a spectrum of inheritance patterns
ranging from simple Mendelian to complex polygenic. Concordance
rates have been reported between 0.73 and 0.92 for monozygotic twins
and between 0.36 and 0.63 for dizygotic twins (Kesling and Reinker
1997; Inoue et al. 1998; Andersen et al. 2007). Despite clear evidence
for the importance of genetics in the susceptibility to IS, limited
progress has been made in the identiﬁcation of genes that are causative or may inﬂuence disease susceptibility, variation, or progression.
The current literature includes multiple studies that have used linkage
and association analyses. Genome-wide linkage analyses have effectively localized candidate regions; however, progress has been burdened by heterogeneity both within and between study populations
and by insufﬁcient statistical power (Wise et al. 2000; Chan et al.
2002; Salehi et al. 2002; Justice et al. 2003; Miller et al. 2005, 2006;
Alden et al. 2006; Ocaka et al. 2008; Gurnett et al. 2009; Raggio
et al. 2009; Clough et al. 2010; Marosy et al. 2010; Edery et al.
2011). Association studies, including genome-wide association studies
(GWAS), have implicated select genes, including CHD7, LBX1, and
GPR126 (Gao et al. 2007; Sharma et al. 2011; Takahashi et al. 2011;
Kou et al. 2013). A recent study has completed exome sequencing for
an IS cohort and identiﬁed rare variants in the ﬁbrillin genes, FBN1
and FBN2, which were associated with curve severity (Buchan et al.
2014).
In the current study, we completed exome sequencing for
a multigenerational family with familial IS, with the goal of identifying
rare genetic variants that contribute to the IS phenotype.

Control populations: Comparisons with control populations used
either the 1000 Genomes population (European ancestry, N = 379)
(Abecasis et al. 2012) or the National Heart, Lung, and Blood Institute
(NHLBI) Exome Sequencing Project [(ESP) European ancestry subset
(EA-ESP), version ESP6500SI-V2, N = 4300].

MATERIAL AND METHODS

Bioinformatics ﬁltering
Exome sequencing reads were mapped to the reference human
genome sequence (hg19) with large-scale alignment software
(GSNAP) (Wu and Nacu 2010). Sequence calls for variants (single
nucleotide variants (SNVs), insertions/deletions) were performed
using the Broad Institute’s Genome Analysis Toolkit (GATK)
(McKenna et al. 2010; Depristo et al. 2011). The resulting variants
were ﬁltered in a systematic way. The program ANNOVAR was used
to ﬁlter the variants by cross referencing various genetic variation
databases (e.g., 1000 genomes database, NHLBI Exome Sequencing
Project 6500 dataset, etc), allowing us to extract information about
variant frequencies (if previously reported) and location within genes
(Wang et al. 2010). Variants were restricted to those that 1) had no
more than a 1% frequency in the phase 1 1000 genomes data (Abecasis
et al. 2012), and 2) altered the coding sequence (nonsense, splice-site,
missense and insertion/deletion). The nonsense and missense variants
were subsequently cross-referenced to the dbNSFP database to determine whether the resulting changes to the protein are predicted to be
damaging (see Supporting Information, File S1) (Liu et al. 2011). In
addition, we required at least 5X sequence coverage at any given position to call a genotype. For the multigenerational family, we required
that all three individuals share the variant if they had a genotype at that
position.
For the St. Louis dataset, next-generation sequencing reads were
aligned to hg19 human reference sequence and variants were called
and annotated, as described by Buchan et al. (2014).

Subjects
Denver IS population: For the Denver IS population, written
informed consent was obtained from study subjects who were enrolled
in accordance with protocols approved by the Johns Hopkins School of
Medicine Institutional Review Board and the University of Colorado
Denver Institutional Review Board (Colorado Multiple Institutional
Review Board, Study Approval #06-1161 and 07-0417). A diagnosis of
IS required clinical/family history and physical examination consistent
with a spinal curvature in the coronal plane, a standing anteroposterior
spinal radiograph showing $10 curvature by the Cobb method with
pedicle rotation, and no congenital deformity or other existing genetic
disorder (Shands and Eisberg 1955; Kane 1977; Armstrong et al. 1982).
Individuals were classiﬁed as having familial IS if they had at least one
additional family member affected with IS (Justice et al. 2003; Miller
et al. 2005). The majority of individuals in our study are likely to
exhibit an autosomal dominant mode of inheritance (Miller et al.
2005, 2012). We collected blood samples from all participants and
extracted genomic DNA according to standard phenol-chloroform
puriﬁcation protocols (Sambrook et al. 1989; Moore and Dowhan
2002) or using the QIAGEN Gentra Puregene Blood Kit.
St. Louis IS population: As described by Buchan et al. (2014), IS
patients in the St. Louis dataset were recruited from St. Louis Children’s
Hospital and St. Louis Shriners Hospital for Children. All patients had
scoliosis of unknown etiology with spinal curves measuring $10.
Patients with developmental delay, multiple congenital anomalies, or
known underlying medical disorders (e.g., Ehlers-Danlos syndrome,
Marfan syndrome) were excluded. We selected 140 unrelated IS cases
of European ancestry with severe deformity (spinal curves measuring $40) for the exome sequencing screen. DNA was collected from
affected probands after we obtained informed consent.
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Exome sequencing
Denver exome sequencing: A multigenerational family with European ancestry was selected for exome sequencing, with DNA samples
available on ﬁve affected and three unaffected individuals (two of the
unaffected individuals are marry-in relatives). This family was selected
based on the number of affected family members with severe curves
and the relative pedigree-distance between affected family members.
Exome capture was performed on 1 mg of genomic DNA from three
affected individuals (IV:1, IV:6, and II:4) in this family using the
Illumina TruSeq Exome Capture kit. Samples were sequenced
with a 2x100bp run at the Illumina HiSeq 2000 at the University of
Colorado Denver Genomics and Microarray Core Facility.
St. Louis exome sequencing: For the St. Louis IS dataset, exon
enrichment was performed using the SureSelect Human All Exon
38Mb and 50Mb kits (Agilent Technologies, Santa Clara, CA) or the
TruSeq Exome Enrichment kit (Illumina, San Diego, CA) at the Washington University Genome Technology Access Center, as described previously (Buchan et al. 2014).

Sanger sequencing
The variants that remained after the ﬁltering process were conﬁrmed
by Sanger sequencing. The variants identiﬁed through exome sequencing were tested in the original three affected individuals who underwent
exome sequencing and ﬁve additional relatives (two affected and
three unaffected). As discussed in the Results section, one variant

(chromosome 6, 168376925, in HGC6.3) had a high frequency in the
EA-ESP population and therefore was not Sanger sequenced.
Primers were designed using the program Primer3 (Koressaar and
Remm 2007; Untergasser et al. 2012). Primer sequences can be found
in Table S1. Sanger sequencing was completed at either the University
of Colorado Denver Barbara Davis Center for Childhood Diabetes or
at Beckman Coulter Genomics. Details of PCR conditions and Sanger
sequencing protocols are located in File S1.
Sanger sequences were analyzed using CodonCode software
(CodonCode Corporation, Centerville, MA), and ﬁgures were generated using Sequencher (GeneCodes Corporation, Ann Arbor, MI).
HSPG2 sequencing
Exons from the HSPG2 gene (97 exons, 14369 base pair mRNA, 4391
amino acids) were sequenced in 100 unrelated individuals with IS. All
individuals had a curvature of .10 with a range of 182119), and
were predominantly of European ancestry. To decrease sequencing
costs, sequencing was completed using 25 pools of four individuals each.
An Illumina MiSeq 2x250bp run was performed at the University of
Colorado Denver DNA Diagnostic Laboratory. The HSPG2 libraries
were enriched using long-range polymerase chain reaction (PCR),
resulting in approximately 2.5 to 10 kb fragments with a Takara long
range PCR kit (Clontech). PCR conditions followed manufacturer’s
recommendations. Primer sequences can be found in Table S1. For
high GC regions, betaine was used in the PCR. A GENios FL (Tecan)
microplate reader using SYBR green was used to quantify the libraries.
The library was generated using a Nextera XT DNA sample kit
(FC-121-1031; Illumina) and Nextera Index kit (FC-121-1011; Illumina).
Bioinformatics ﬁltering was completed using the same protocol as
described earlier. The ﬁltering process resulted in 14 potentially
damaging and rare HSPG2 variants in these 100 individuals. The 14
variants were Sanger sequenced in each of the four individuals within
the pool to conﬁrm the variant and identify the individual within the
pool that carried the variant. The Sanger sequencing protocol was the
same as described for the multigenerational family. We were unable to
conﬁrm an HSPG2 variant at position 22263709 (p.Met1Thr) due to
problems with the PCR-ampliﬁcation process. This variant was removed from all further analyses, resulting in a total of 13 rare variants
in the HSPG2 gene.
The median sequencing coverage across the HSPG2 gene was
172X, with a range of 45X to 349X. Exons 27242 had lower coverage
in multiple pools, where the median coverage was 68X across these 16
exons. Due to these concerns with sequence quality, we chose to
Sanger sequence all 100 IS individuals for all 13 variants to conﬁrm
the variant frequency in our population.
Statistical comparisons
The Fisher’s exact test (two-sided) was used to calculate the P-values
for comparisons between the IS population(s) and the 1000 Genomes
European population or the EA-ESP, with a = 0.05. Mutalyzer 2.0.
beta-31 was used to generate and check all nucleotide and protein
positions (Wildeman et al. 2008), and positions were veriﬁed using
MutationTaster and the public version of the Human Gene Mutation
Database (HGMD) (Schwarz et al. 2014; Stenson et al. 2014).
RESULTS
Exome sequencing identiﬁes an HSPG2 variant in an
IS family
We studied a multigenerational family affected with familial IS and of
European ancestry (Figure 1A). Affected individuals were diagnosed

with familial IS based on radiographic ﬁndings of a spinal curvature of
$10. The proband, individual III:2, was diagnosed at 13 years of age
with a right thoracic curve and a left lumbar curve of 60 and 40,
respectively, and underwent posterior spinal instrumentation and fusion. The transmission pattern in this family suggested a Mendelian
mode of inheritance, for which exome sequencing is ideally suited.
Exome sequencing, followed by variant detection and ﬁltering, was
completed for three individuals in this family. Sequencing coverage
was 64· overall, with IV:1, IV:6, II:4 at 97X, 82X, and 22X respectively. Filtering resulted in a list of 16 variants that were at a frequency
of ,1% in the 1000 Genomes data, were predicted to be damaging
(according to the criteria deﬁned in the Materials and Methods section
and File S1), and were insertions/deletions, nonsense, missense, or
splice-site changes. In addition, to be considered for further study,
variants were required to be present in all three affected individuals in
the family.
After the ﬁltering process, 16 potentially damaging and rare variants
were identiﬁed in this family (Table 1 and Table S2). One variant
was removed due to an excessive frequency in the EA-ESP dataset
(in HGC6.3, 23% frequency in EA-ESP). For each of the remaining 15
variants, Sanger sequencing was completed for the individuals who
originally underwent exome sequencing and for additional relatives with
DNA samples [two affected and three unaffected (two of the unaffected
individuals were marry-in relatives)]. Sanger sequencing was unable to
replicate the original result for 1 of the 15 variants (OPRD1) in the
original three exome sequenced individuals (Table S3).
After ﬁltering and Sanger sequencing, there were 14 variants of
interest (Table 1). Therefore, we surveyed the literature for mouse and
human phenotypic associations. Previously reported mouse phenotypes for loss-of-function mutations in 13 of the 14 genes produced
either phenotypes not clearly associated with musculoskeletal disease
or had no evident phenotype. Those 13 genes also have no reported
association with a human musculoskeletal phenotype.
The single remaining variant is NM_005529.5:p.Asn786Ser, a heterozygous missense variant in the HSPG2 gene (MIM 142461) on
chromosome 1p36. All of the affected individuals in this family are
heterozygous for this variant (CT genotype) (Figure 1B). Of the three
unaffected individuals, two are homozygous for the reference allele
(TT genotype) and one is heterozygous (IV:2, CT genotype). The
presence of the CT genotype in an unaffected male may be due to
incomplete penetrance of the IS phenotype.
HSPG2 encodes for heparan sulfate proteoglycan 2, or perlecan.
Perlecan is a key component of basement membranes and is strongly
associated with musculoskeletal development, both in mouse and in
human (Costell et al. 1999; Nicole et al. 2000; Arikawa-Hirasawa et al.
2001b; Stum et al. 2006; Rodgers et al. 2007), making it an excellent
candidate gene for IS.
Sequencing of the HSPG2 gene in 100 individuals
with IS
Seeking to further our knowledge of the importance of the HSPG2
gene in IS, we designed an HSPG2 sequencing project. Exons from the
HSPG2 gene (97 exons, 14,369 base pair mRNA, 4391 amino acids)
were sequenced in 100 unrelated individuals with IS (Denver dataset,
curvature range 182119) with a custom targeted gene approach on
an Illumina MiSeq platform. After variant ﬁltering using the bioinformatic pipeline described previously, we found 14 potentially damaging
and rare HSPG2 variants. Again, variants were deﬁned as potentially
damaging according to our criteria deﬁned in the Materials and Methods section and File S1, and rare if the frequency was ,1% in the 1000
Genomes database. We were unable to conﬁrm one variant with
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Figure 1 (A) Pedigree for the multigenerational
family with IS. Individuals IV:1, IV:6, and II:4 underwent exome sequencing. Sanger sequencing
was completed for those three individuals in
addition to the affected individuals III:2 and III:6
and unaffected individuals III:1, III:7, and IV:2.
Lumbar and thoracic curves are abbreviated with
L and T, respectively. Double curves are represented by a slash (right thoracic/left lumbar), and
triple curves are represented with three slashes (left
high thoracic/right thoracic/left lumbar). CT or TT is
the individual genotype at HSPG2 position p.
Asn786Ser. A “?” represents individuals that have
not been examined, so their scoliosis status is unknown. (B) Chromatograms for Variant p.
Asn786Ser. Chromatograms for p.Asn786Ser are
shown for two individuals from the multigenerational family (III:6, affected, and III:7, unaffected).
The variant p.Asn786Ser, in the HSPG2 gene, is
heterozygous in the affected individuals within the
family, but not in the unaffected individuals (with
the exception of IV:2, as discussed in the section
Results).

Sanger sequencing, and it was consequently removed from further
analyses (see the section Materials and Methods). Each variant had
a frequency of ,1% in the 1000 Genomes database, and 3 of the 13
identiﬁed variants were unique (not previously identiﬁed in the 1000
genomes data or in the NHLBI ESP; Table 2 and Table S4). All 13
variants were tested by Sanger sequencing in all 100 individuals to
assess variant frequencies in our IS population. Including one individual from our multigenerational family (IV:1), we had a total of 101
individuals with 20 occurrences of HSPG2 variants. One individual
had two HSPG2 variants.
One of the 13 variants was the same variant previously identiﬁed
from the exome sequencing of our multigenerational IS family (p.
Asn786Ser). This speciﬁc variant was heterozygous in 3 of the 100
additional sequenced individuals. In the 1000 Genomes data, this
variant was only found in four individuals, all male (three from the
European subset and one from the Puerto Rican subset). This
difference is signiﬁcant, with the CT genotype present in 4 of 101
IS individuals compared with 3 of 379 1000 Genomes European
individuals [P = 0.039, odds ratio (OR) 5.2, 95% conﬁdence interval
(95% CI) 0.96230]. However, the difference is not signiﬁcant when
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we compare with the EA-ESP dataset (77/4300 individuals, P = 0.114,
OR 2.3, 95% CI 0.6926.6). This is potentially related to the small
number of individuals sequenced in our study (N = 101 individuals)
compared with the EA-ESP database (N = 4300).
In summary, in the Denver IS dataset, we identiﬁed 13 potentially
damaging and rare variants in the HSPG2 gene, with 20 occurrences
in 101 individuals with IS. This ﬁnding provides further support that
HSPG2 may have an important role in IS etiology.
Further investigation of the HSPG2 ﬁnding in an
independent IS population
Next, we investigated HSPG2 damaging variants in the exome sequencing data from an independent group of 140 IS individuals (St.
Louis dataset). We identiﬁed 7 of the original 13 Denver HSPG2
variants in this St. Louis dataset, including p.Asn786Ser. The CT
genotype for this variant is present in six individuals in the St. Louis
dataset (compared with 77/4300 EA-ESP, P = 0.046, OR = 2.5, 95% CI
0.95-6.0). Furthermore, an additional 11 potentially damaging variants
in HSPG2 were discovered that were not previously identiﬁed in the
Denver IS group, for a total of 18 HSPG2 variants in the St. Louis

n Table 1 Rare variants (MAF 0.01)a identiﬁed in our multigenerational family with ISb
Chr

HGVS Protein
Position

Position

Gene

rs #

Ref

Var

Chr1
Chr1
Chr1
Chr1
Chr1
Chr1
Chr4
Chr6

22205601
23233346
28060600
29189481
45524416
51873967
77662160
43483718

HSPG2
EPHB2
FAM76A
OPRD1c
ZSWIM5
EPS15
SHROOM3
YIPF3

rs143736974
rs28936395
rs147811051
rs370180812
rs149382804
rs61753384
rs368255851

T
G
G
G
G
G
A
GCAT

C
A
A
T
A
A
T
G

p.N786S
p.D679N
p.R121H
p.A269S
p.R373W
p.S438L
p.D945V
p.D65del

Chr6

168376925

HGC6.3d

rs35001101

G

GT

p.T137Hfs7

Chr7

139281560

HIPK2

T

TCTGCCG

Chr7
Chr7
Chr8
Chr8
Chr10
ChrX

149473614
150934827
132051970
133883671
112570222
132092485

SSPO
CHPF2
ADCY8
TG
RBM20
HS6ST2

A
G
C
C
T
G

G
A
A
T
TGAG
A

rs117048984
rs144589067
rs75246765
rs114322847
rs181526961

p.Q873_T874insRQ
p.Y77C
p.R460Q
p.A204S
p.P118L
N/A
p.S49L

Variant
Type

1000 Genomes
Frequency

EA-ESP
Frequency

Missense
Missense
Missense
Missense
Missense
Missense
Missense
Nonframeshift
deletion
Frameshift
insertion
Nonframeshift
insertion
Missense
Missense
Missense
Missense
Splicing
Missense

0.0018
0.0023

0.009
0.0071
0.00081
0.00017
0.0014
0.022
0.00012
0.0095

0.00046
0.0064

0.24

0.0018
0.006
0.0087
0.006

0.04
0.0039
0.016
0.022
0.0027
0.0097

MAF, minor allele frequency; IS, idiopathic scoliosis; Chr, chromosome; Ref, reference allele; Var, variant allele; EA-ESP, European American Exome Sequencing
Project.
a
The original MAF ﬁlter used the 1000 genomes frequency.
b
Additional details for each variant are provided in Table S2.
c
Variant in the OPRD1 gene was not present in all of the affected individuals in the family and was removed from further analyses.
d
Variant in the HGC6.3 gene was removed from further analyses due to the high frequency in the EA-ESP population.

dataset (Table 2 and Table S4). We tested all 18 variants by Sanger
sequencing and found that three low-quality variants did not conﬁrm,
resulting in 15 veriﬁed HSPG2 variants from the St. Louis dataset. One
individual had two HSPG2 variants.
Collectively, in the combined Denver-St. Louis IS population, the
data for the p.Asn786Ser variant are compelling. There are 10 IS
individuals with a CT genotype of 241 individuals total. We compared

this with 77 of 4300 in the EA-ESP population and found that the CT
genotype is signiﬁcantly enriched in the combined IS population (P =
0.024, OR 2.4, 95% CI 1.124.8).
Overall, 21 potentially damaging and rare variants in HSPG2 were
identiﬁed in the combined Denver-St. Louis IS population, with 48
occurrences in 241 individuals. The variants are distributed across the
HSPG2 gene (Figure 2).

n Table 2 HSPG2 rare variants (MAF ,0.01)a Identiﬁed in individuals with ISb
Position
22149967
22150639
22150854
22154901
22155345
22155455
22155960
22159039
22161394
22168855
22169325
22182115
22182333
22186669
22188289
22188328
22202483
22205601
22206959
22206977
22211941

rs #

Ref

Var

HGVS
Positionc

Variant
Type

rs145687082
rs141280063

C
C
C
G
G
C
C
C
C
G
C
G
G
C
G
C
G
T
A
C
G

T
T
T
A
A
A
T
T
T
A
T
A
A
T
A
T
A
C
G
T
T

p.V4340M
p.E4292K
p.G4254S
p.R4086W
p.R4074C
p.R4037L
p.G3970R
p.R3719Q
p.V3500M
p.R2977W
p.G2950R
p.R1919C
p.A1883V
N/A
p.T1639M
p.R1626H
p.P1019L
p.N786S
p.Y698H
p.V692M
p.T361N

Missense
Missense
Missense
Missense
Missense
Missense
Missense
Missense
Missense
Missense
Missense
Missense
Missense
Splicing
Missense
Missense
Missense
Missense
Missense
Missense
Missense

rs146179360
rs140139732
rs143015575
rs78280998
rs143543800
rs114851469
rs41266007
rs2229474
rs140954748
rs142433309
rs41311989
rs62642528
rs143736974
rs143669458
rs75467696

1000 Genomes
Frequency

EA-ESP
Frequency

Denver
(N = 101)

0.0014
0.00047

1
1
1

0.0012
0.0014
0.00082

1

St. Louis
(N = 140)

1
1
1

1
1
0.0018
0.0032
0.0078
0.0041

0.0041
0.012
0.02
0.0087
0.0012

0.0009
0.006
0.0018

0.0036
0.0011
0.014
0.009

0.00092
0.0023

0.0033
0.0066

1
3
1
1
2 (1 has AA)
1
2
4

5
4
2
1
1
1
1
6
1
1
1

IS Allele
Frequency
0.0021
0.0021
0.0021
0.0021
0.0041
0.0021
0.0021
0.0021
0.0021
0.010
0.015
0.0062
0.0021
0.0021
0.0083
0.0041
0.0062
0.021
0.0021
0.0021
0.0021

MAF, minor allele frequency; IS, idiopathic scoliosis; Ref, reference allele; Var, variant allele EA-ESP, European American Exome Sequencing Project.
a
The original MAF ﬁlter used the 1000 genomes frequency.
b
Additional details for each variant are provided in Table S4.
c
HSPG2 HGVS positions use NM_005529.
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Figure 2 Rare HSPG2 variants identiﬁed in IS patients. Structure of the HSPG2 protein showing the amino acid positions of the rare coding
variants identiﬁed in the combined IS cohort of 241 individuals. Amino acid positions are based on transcript NM_005529.5. Variant p.Asn786Ser
is the original variant identiﬁed in this study (combined Denver2St. Louis dataset, P = 0.024, odds ratio 2.4). Also note that variant 22186669
(c.5014+1G . A) is not shown on the diagram because it is a splicing variant and does not have an amino acid position. IS, idiopathic scoliosis.

DISCUSSION
We performed exome sequencing for a multigenerational family with
familial IS and identiﬁed a potentially damaging and rare variant in
the HSPG2 gene. Our previous linkage results were reviewed for potential correlation with the location of newly identiﬁed variants (Miller
et al. 2005, 2006; Alden et al. 2006; Clough et al. 2010; Marosy et al.
2010). When this particular family was analyzed individually, marginal linkage signals were noted at nine loci (Miller, unpublished data,
2014). One of these loci, located on chromosome 1 (19248.3 Mb),
contains the HSPG2 gene. These ancillary linkage data provide additional evidence that a variant within HSPG2 potentially contributes to
the IS phenotype in this family.
Upon further sequencing of the HSPG2 gene in an additional 100
individuals with IS, we identiﬁed 13 potentially damaging and rare
variants in HSPG2, with 20 occurrences in 101 individuals. Finally,
using exome sequencing data from a second IS population, we found
15 variants in HSPG2. Combined, we found 21 rare variants with 48
occurrences in 241 individuals with IS. Speciﬁcally, p.Asn786Ser was
present in 10 individuals in our dataset and is enriched in these two
IS populations when compared with the EA-ESP dataset (P = 0.024,
OR 2.4).
HSPG2 encodes for heparan sulfate proteoglycan 2, or perlecan.
Perlecan is a modular proteoglycan consisting of ﬁve structural core
domains to which long chains of glycosaminoglycans (GAGs: heparan
sulfate or chondroitin sulfate) are attached (Figure 2) (Murdoch et al.
1992). Domain I, the N-terminal domain, is unique to perlecan and
has three attachment sites for heparan sulfate/chondroitin sulfate
chains. Domain II is homologous to low-density lipoprotein (LDL)
receptor sites. Domain III consists of multiple modules homologous to
laminin alpha chains and laminin epidermal growth factor-like (EGFlike) repeats and is divided into three subdomains (III-1, III-2, III-3)
(Schulze et al. 1996). Fibroblast growth factor-7 (FGF-7), plateletderived growth factor (PDGF), and von Willebrand A-domain related
protein (WARP) are known to bind subdomains III-1, III-2, and III-2,
respectively (Gohring et al. 1998; Mongiat et al. 2000; Allen et al.
2006). The largest domain, domain IV, contains multiple immunoglobulin G2like (IgG-like) repeats similar to neural cell adhesion molecules. Domain V, at the C-terminus of the protein, has homology to
the globular domain of laminin and contains a GAG attachment and
EGF-like repeats. This domain interacts with cell-surface integrins
(a2b1), forming additional complexes linking the extracellular matrix
(ECM) with the cell, and is responsible for perlecan self-assembly (Bix
et al. 2004).
Perlecan stabilizes the ECM and is localized to basement
membranes, vascular structures, cartilage, and osteogenic tissues
(Costell et al. 1999). This protein is abundantly expressed by skeletal
myoﬁbers and is incorporated into the basal lamina of both the synaptic and extrasynaptic regions within the neuromuscular junction
(NMJ) (Singhal and Martin 2011). Perlecan binds multiple proteins
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and signaling molecules {including FBN1 [previously implicated in IS
(Buchan et al. 2014)], FGF-7, latent transforming growth factor-beta
binding protein-2 (LTBP-2)}, indicating it has a role as an ECM signaling scaffold with an ability to participate in cellular proliferation,
differentiation, and migration (Arikawa-Hirasawa et al. 1999; FarachCarson and Carson 2007; Hayes et al. 2011; Hayes et al. 2014). Perlecan
is strongly associated with musculoskeletal development because it is
essential for endothelial growth, regeneration, and both avascular
cartilage and skeletal development, making HSPG2 an excellent gene
candidate for IS.
Classically, pathogenic mutations in the FBN1 gene result in Marfan syndrome, a multisystem disorder that includes the musculoskeletal
abnormality of scoliosis. Early investigations noted FBN1 abnormalities
in the paraspinal tissues and ﬁbroblasts of select individuals with severe
IS (Miller et al. 1996). Most recently, Buchan et al. (2014) identiﬁed
rare variants in the FBN1 gene as risk factors for severe spinal deformity in individuals with IS (Buchan et al. 2014). Collectively,
these ﬁndings and the known colocalization of perlecan and FBN1
within paraspinal tissues make HSPG2 an excellent candidate gene
for IS pathogenesis.
Mutations within the HSPG2 gene have been associated with two
human diseases transmitted in an autosomal recessive pattern of inheritance, Schwartz-Jampel syndrome, type 1 (SJS1) [MIM: #255800]
and dyssegmental dysplasia Silverman-Handmaker type (DDSH)
[MIM: #224410]. Individuals with SJS1 are characterized by a skeletal
dysplasia, including kyphoscoliosis, joint contractures, and myotonia
resulting in a ﬁxed facial expression and prolonged muscle contractions (Nicole et al. 2000; Stum et al. 2006). SJS1 mutations occur
throughout the HSPG2 gene and are not concentrated in a speciﬁc
exon or domain (Table S5) (Nicole et al. 2000; Arikawa-Hirasawa
et al. 2002; Stum et al. 2006; Rodgers et al. 2007). In SJS1, the mutated
proteins have varying degrees of functionality. Animal models have
shown site-speciﬁc mutations of the gene, which result in down-regulation of perlecan at the transcriptional level (Rodgers et al. 2007). In
contrast, DDSH is a more severe phenotype than SJS1 and is considered lethal (Arikawa-Hirasawa et al. 2001b). The causative mutational
events for DDSH are functional null mutations, resulting in a truncated perlecan protein core that is not secreted (Table S5) (ArikawaHirasawa et al. 2001a). This is similar to the Hspg2 homozygous
knockout mouse, which exhibits signiﬁcant kyphoscoliosis and skeletal defects (Costell et al. 1999). Thus, homozygous HSPG2 mutations
in humans and mice display a more severe phenotype with an earlier
onset compared with the adolescent-onset FIS phenotype in individuals with heterozygous HSPG2 variants. This ﬁnding suggests that
haploinsufﬁciency may result in a later onset and progressive disease,
as observed in FIS.
Similar to SJS1 mutational events, the variants we identiﬁed in IS
individuals are spread out across the HSPG2 gene. Our original variant (p.Asn786Ser) is located in domain III-1, which is known to bind

FGF-7 (Figure 2). One IS individual has a damaging variant (22202483,
p.Pro1019Leu) at a base position also identiﬁed in SJS1 individuals
(Stum et al. 2006). However, this variant has an allele frequency of
1.3% in the EA-ESP and thus is unlikely to be solely causative for
SJS1, based on a predicted homozygote frequency of 0.018%.
We completed a test of variant burden across the entire HSPG2
gene, comparing the occurrence of potentially damaging and rare
variants in individuals with IS to the EA-ESP control population.
We used a Z test for population proportions to compare the number
of variant occurrences in the two populations. Using the overall combined dataset, we found there were 48 occurrences in 241 individuals
with IS compared with 720 occurrences in 4300 individuals in the EAESP dataset (P = 0.20). If we remove the variants in perlecan domain
IV from both datasets, because domain IV is highly repetitive and the
functions are more likely to be redundant within the gene, there are 31
occurrences in 241 individuals with IS compared with 385 occurrences
in 4300 individuals in the EA-ESP dataset (P = 0.040). This marginally
signiﬁcant result increases our conﬁdence that variants in HSPG2
contribute to the IS phenotype, but sequencing in additional individuals with IS will be needed to draw strong conclusions.
IS, deﬁned as a lateral spinal curvature of at least 10, is present in
3% of the general population and can lie undetected within many
individuals. Thus, a variant that contributes to the IS phenotype could
be expected to be present in a control population at a reasonably high
frequency. In addition, IS is characterized by incomplete penetrance,
so not all individuals who carry a variant are expected to have clinical
disease, as seen with individual IV:2, who is unaffected but is heterozygous at the variant of interest (p.Asn786Ser). Finally, we do not
expect that one gene is causative for IS in all individuals. We believe
that HSPG2 may contribute to the IS phenotype in a subset of individuals with IS but that other genes may be required to modify the
disease and result in clinical/identiﬁable disease (i.e., another variant
in a different gene may also be required to have a larger/progressive
curvature). Future studies should include both sequencing the HSPG2
gene in larger IS cohorts and performing functional studies of the
identiﬁed variants to provide conﬁrmation that the variants contribute
to the IS phenotype.
In summary, IS is a complex disease. Genetic ﬁndings have been
hampered by incomplete penetrance, subclinical disease in control
populations, unknown modes of inheritance, and genetic heterogeneity. Additionally, IS may be a polygenic disease, even within families. By demonstrating the presence of the p.Asn786Ser variant in all
affected individuals in a multigenerational family, with incomplete
penetrance in one unaffected individual, and enrichment of this variant in two independent cohorts of IS patients, we now have evidence
that rare variants in the HSPG2 gene potentially contribute to IS
susceptibility.
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